Deskripsi
Overview of the major bioactive constituents of Ginkgo biloba leaf extract (EGb 761), including flavonoid glycosides and terpene lactones (ginkgolides and bilobalide), with their pharmacological targets in aging-related diseases.
Figure 1
DiagramSource Paper
Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Diseases.Cite This Figure
![Figure 1: Overview of the major bioactive constituents of Ginkgo biloba leaf extract (EGb 761), including flavonoid glycosides and terpene lactones (ginkgolides and bilobalide), with their pharmacological targets in aging-related diseases.]() > Source: Wei Zuo et al. "Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Disease." *Aging and disease*, 2017. PMID: [29344418](https://pubmed.ncbi.nlm.nih.gov/29344418/)
<figure> <img src="" alt="Overview of the major bioactive constituents of Ginkgo biloba leaf extract (EGb 761), including flavonoid glycosides and terpene lactones (ginkgolides and bilobalide), with their pharmacological targets in aging-related diseases." /> <figcaption>Figure 1. Overview of the major bioactive constituents of Ginkgo biloba leaf extract (EGb 761), including flavonoid glycosides and terpene lactones (ginkgolides and bilobalide), with their pharmacological targets in aging-related diseases.<br> Source: Wei Zuo et al. "Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Disease." <em>Aging and disease</em>, 2017. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29344418/">29344418</a></figcaption> </figure>